Home › Trial NCT03057418
Open-label Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Auriхim
- Trial IDNCT03057418
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorBiointegrator LLC
- Enrollment7
- Start date2013-06
- ConditionsLymphoma, Non-Hodgkin · Lymphoma, Follicular
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.